Pfizer, Moderna to Expand Vaccine Studies in Young Children
TUESDAY, July 27, 2021 (HealthDay News) — Pfizer and Moderna are expanding trials of their COVID-19 vaccines in children ages 5 to 11, to more closely measure the risk of heart inflammation and other rare side effects that occurred in teens and young adults who received the vaccines. The companiesContinue Reading










